225Ac-FAP-2286
N/A
Report date: 2025/11/20 16:00:53
NME
Base Information
Drug Name225Ac-FAP-2286
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClovis Oncology Inc
China Registration ClassN/A
Develop Information
Active Companies3B Pharmaceuticals GmbHClovis Oncology IncNovartis Pharma Ag
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A